Targeting Neuroinflammation in Brain Cancer: Uncovering Mechanisms, Pharmacological Targets, and Neuropharmaceutical Developments
Gliomas are one of the most lethal types of cancers accounting for ∼80% of all central nervous system (CNS) primary malignancies. Among gliomas, glioblastomas (GBM) are the most aggressive, characterized by a median patient survival of fewer than 15 months. Recent molecular characterization studies...
主要な著者: | Mahmoud S. Alghamri, Brandon L. McClellan, Carson S. Hartlage, Santiago Haase, Syed Mohd Faisal, Rohit Thalla, Ali Dabaja, Kaushik Banerjee, Stephen V. Carney, Anzar A. Mujeeb, Michael R. Olin, James J. Moon, Anna Schwendeman, Pedro R. Lowenstein, Maria G. Castro |
---|---|
フォーマット: | 論文 |
言語: | English |
出版事項: |
Frontiers Media S.A.
2021-05-01
|
シリーズ: | Frontiers in Pharmacology |
主題: | |
オンライン・アクセス: | https://www.frontiersin.org/articles/10.3389/fphar.2021.680021/full |
類似資料
-
Murine brain tumor microenvironment immunophenotyping using mass cytometry
著者:: Brandon L. McClellan, 等
出版事項: (2022-06-01) -
Impact of epigenetic reprogramming on antitumor immune responses in glioma
著者:: Brandon L. McClellan, 等
出版事項: (2023-01-01) -
Genetic Alterations in Gliomas Remodel the Tumor Immune Microenvironment and Impact Immune-Mediated Therapies
著者:: Maria B. Garcia-Fabiani, 等
出版事項: (2021-06-01) -
Development of immunotherapy for high-grade gliomas: Overcoming the immunosuppressive tumor microenvironment
著者:: Andrea Franson, 等
出版事項: (2022-09-01) -
H3.3-G34 mutations impair DNA repair and promote cGAS/STING-mediated immune responses in pediatric high-grade glioma models
著者:: Santiago Haase, 等
出版事項: (2022-11-01)